(Q30391526)

English

Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: a phase I-II randomized trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: a phase I-II randomized trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

phase I clinical trial

0 references

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

author name string

Jiang Wu

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Shu-Zhen Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Shan-Shan Dong

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Xiao-Ping Dong

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Wu-Li Zhang

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Min Lu

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Chang-Gui Li

7

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Ji-Chen Zhou

8

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Han-Hua Fang

9

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Yan Liu

10

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Li-Ying Liu

11

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Yuan-Zheng Qiu

12

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Qiang Gao

13

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Xiao-Mei Zhang

14

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Jiang-Ting Chen

15

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Xiang Zhong

16

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Wei-Dong Yin

17

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Zi-Jian Feng

18

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

16 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

6221-6227

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.008

7 January 2021

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.008

7 January 2021

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.008

7 January 2021

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.008

7 January 2021

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.008

7 January 2021

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.008

7 January 2021

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.008

7 January 2021

Safety, humoral and cell mediated immune responses to two formulations of an inactivated, split-virion influenza A/H5N1 vaccine in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.008

7 January 2021

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.008

7 January 2021

Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.008

7 January 2021

Avian influenza A (H5N1) infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.008

7 January 2021

Antibody persistence after 2-dose priming and booster response to a third dose of an inactivated, adjuvanted, whole-virion H5N1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.008

7 January 2021

Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.008

7 January 2021

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.008

7 January 2021

The economic impact of pandemic influenza in the United States: priorities for intervention.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.008

7 January 2021

Social contact networks for the spread of pandemic influenza in children and teenagers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.008

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.07.008

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30391526&oldid=1749474886"